Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double blind, placebo and active controlled, dose-ranging, phase 2 trial
O’Neil PM, Birkenfeld AL, McGowan B, et al.
Lancet 2018;392(10148):637-49
Leggi